Impact of varying knowledge investment by F. by Muhammad Fahimullah (6940703)

Nielsen scanner data trend in nonpromotional price for unsweetened beverages. by Osama M. El-Sayed (11920046)

Nielsen scanner data trend in discount amount for noncalorically sweetened beverages. by Osama M. El-Sayed (11920046)

Nielsen scanner data trend in nonpromotional price for noncalorically sweetened beverages. by Osama M. El-Sayed (11920046)

Impact of trust level. by Muhammad Fahimullah (6940703)

Nielsen scanner data trend in discount amount for unsweetened beverages. by Osama M. El-Sayed (11920046)

Nielsen scanner data trend in discount amount for sugar-sweetened beverages. by Osama M. El-Sayed (11920046)

Nielsen scanner data trend in nonpromotional price for sugar-sweetened beverages. by Osama M. El-Sayed (11920046)

Knee flexion. by Marina Hitz (5513735)

EEG to Primary Rewards: Predictive Utility and Malleability by Brain Stimulation - Fig 6 by Nicole Prause (3371267)

Confirmatory factor analysis of the second order measurement model. by Kalaya Kongwattanakul (8697987)

Lower contributions, stronger punishment. by Mohammad Salahshour (10113796)

Baseline characteristics of participants by gender and MTHFR genotype. by Leopold K. Fezeu (5309333)

Patients’ characteristics. by Ciputra Adijaya Hartana (5474756)

Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c by Michiko Narita (124347)

“…Interestingly, the inhibition of both miR-155 and miR-200c in HCC827 cells without gefitinib induced significant increases in smad2 and zeb1 along with a dramatic decrease in E-cadherin and a slight increase in vimentin. …”

EEG to Primary Rewards: Predictive Utility and Malleability by Brain Stimulation - Fig 4 by Nicole Prause (3371267)

Impact of the individual objectives of firms over financial revenue and learning payoff. by Muhammad Fahimullah (6940703)

Results from the control experiment (Exp. 1). by Laura Tiano (524349)

EEG to Primary Rewards: Predictive Utility and Malleability by Brain Stimulation - Fig 3 by Nicole Prause (3371267)

Supplementary Material for: Mortality and Cardiovascular Morbidity Associated with Haemoglobin Levels: A Pooled Analysis of Randomised Controlled Trials by Locatelli F. (3698788)

“…Hazard ratios and 95% confidence intervals were calculated. <b><i>Results:</i></b> Average Hb <10 g/dl, decrease from stable baseline Hb >1 g/dl, last Hb <10 g/dl, Hb decline >1.5 g/dl/4 weeks and increased Hb variability were associated with a higher risk of the composite end point and all-cause mortality. …”